Matthew D. Galsky

3 ta ish

Icahn School of Medicine at Mount Sinai

1. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

   Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles +28

   MaqolaOAOchiq kirish20163 iqtibos

   ABIABI:AkademIndex/2026.other.097028

2. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

   Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah +97

   MaqolaOAOchiq kirishCOVID-19 and healthcare impactsThe Lancet20202 iqtibos

   ABIABI:AkademIndex/2026.other.000032

3. Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

   Guru Sonpavde, Phillip Periman, D. M. Bernold +8

   MaqolaOAOchiq kirish20092 iqtibos

   ABIABI:AkademIndex/2026.other.011725